Today's News |
Accel-Rx Recognized with Two Global Awards including 'Best Health Science Accelerator in Canada'
Monday, October 7, 2019Company Profile | Follow Company
Vancouver, BC, September 28, 2019--(T-Net)--Accel-Rx, Canada's health sciences accelerator, has been recognized as the 'Best Health Science Accelerator in Canada,' and 'Seed Investment Experts of the Year' in the 2019 Global Healthcare & Pharmaceutical (GHP) Awards.
The winners of the awards honour those who provide the highest quality of care and medical products available, and pay homage to those whose innovative work within the life sciences industry contributes towards furthering the advancement of health in an ever-expanding and demanding sector.
As seed investment specialists, Accel-Rx stewards early-stage companies selected from across the country to a level where they can successfully raise a Series A or equivalent financing. Through a unique growth platform that provides access to capital, industry connections, mentorship and customized guidance, the Accel-Rx formula is designed to stimulate Canada's health sciences sector and ensure our innovations become competitive on a global scale.
Katherine Benton, GHP Awards Co-ordinator, explains: "These awards highlight, beyond a shadow of a doubt, that our winners outshine the competition and are committed to giving their service users the support they need. With the healthcare and pharmaceutical markets among the most important in the entire corporate landscape, I am proud to be able to showcase the winners of this prestigious awards programme for 2019."
Read all about the reasons behind Accel-Rx's win here.
About Accel-Rx
The Accel-Rx Health Sciences Accelerator is a national organization focused on maximizing new health sciences company creation & ensuring start-ups have the resources to stay and grow in Canada and become a new generation of strong health sciences anchor companies.
Accel-Rx is working towards its vision of a well-anchored and vibrant Canadian health sciences industry by building on and leveraging the strengths of existing research and commercialization centres such as the existing health-related Centres of Excellence for Commercialization and Research (CECRs), and then providing the critical complementary capacity and resources to specifically support new company creation including:
Seed capital through the Business Development Bank of Canada, a founding partner of Accel-Rx;
A new national network of entrepreneurs to drive and guide company creation; Partnerships with the venture capital community to facilitate follow-on financings as well as provide early business feedback;
Access to and commercial input from strategic industry partners;
Access to business/finance/development expertise, technical capabilities and specialized infrastructure;
Specialized entrepreneurial training to enable young, driven individuals to become the next generation of company creators and bio-entrepreneurs;
Regular meetings and events to bring together these investors, entrepreneurs, researchers, industry partners, and technology developers. With these resources Accel-Rx is providing Canada with a new more well-informed, well-resourced, and effective approach to company creation; and ensure that opportunities arising from the country's strong foundation of innovative discovery research and technology development are fully capitalized upon through the launching of a critical mass of robust companies based on exceptional innovative, pre-validated (scientifically and commercially) technologies.
Other Recent Company News |
||||||||||
|